The carbohydrate moiety of factor V modulates inactivation by activated protein C

被引:19
作者
Fernandez, JA
Hackeng, TM
Kojima, K
Griffin, JH
机构
[1] Scripps Res Inst, DEPT MOL & EXPT MED, LA JOLLA, CA 92037 USA
[2] Scripps Res Inst, DEPT VASC BIOL, LA JOLLA, CA 92037 USA
关键词
D O I
10.1182/blood.V89.12.4348
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An important risk factor for thrombosis is the polymorphism R506Q in factor V that causes resistance of factor Va to proteolytic inactivation by activated protein C (APC). To study the potential influence of the carbohydrate moieties of factor Va on its inactivation by APC, factor V was subjected to mild deglycosylation (neuraminidase plus N-glycanase) under nondenaturing conditions. The APC resistance ratio values (ratio of activated partial thromboplastin time [APTT] clotting times with and without APC) of the treated factor V were increased (2.4 to 3.4) as measured in APTT assays. O-glycanase treatment of factor V did not change the APC resistance ratio. The procoagulant activity of factor V as well as its activation by thrombin was not affected by mild deglycosylation. Treatment of factor V with neuraminidase and N-glycanase mainly altered the electrophoretic mobility of the factor Va heavy chain, whereas treatment with O-glycanase changed the mobility of the connecting region. This suggests that the removal of the N-linked carbohydrates from the heavy chain of factor Va, which is the substrate for APC, is responsible for the increase in susceptibility to inactivation by APC. Thus, variability in carbohydrate could account for some of the known variability in APC resistance ratios, including the presence of borderline or low APC resistance ratios among patients who lack the R506Q mutation. (C) 1997 by The American Society of Hematology.
引用
收藏
页码:4348 / 4354
页数:7
相关论文
共 33 条
[1]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[2]  
BERTINA RM, 1995, THROMB HAEMOSTASIS, V74, P449
[3]   ENZYMATIC REMOVAL OF SIALIC-ACID FROM HUMAN FACTOR-IX AND FACTOR-X HAS NO EFFECT ON THEIR COAGULANT ACTIVITY [J].
BHARADWAJ, D ;
HARRIS, RJ ;
KISIEL, W ;
SMITH, KJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (12) :6537-6542
[4]   THE FUNCTION OF THE HUMAN FACTOR-V CARBOHYDRATE MOIETY IN BLOOD-COAGULATION [J].
BRUIN, T ;
STURK, A ;
TENCATE, JW ;
CATH, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 170 (1-2) :305-310
[5]  
COLUCCI M, 1994, THROMB HAEMOSTASIS, V72, P985
[6]   FAMILIAL THROMBOPHILIA DUE TO A PREVIOUSLY UNRECOGNIZED MECHANISM CHARACTERIZED BY POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - PREDICTION OF A COFACTOR TO ACTIVATED PROTEIN-C [J].
DAHLBACK, B ;
CARLSSON, M ;
SVENSSON, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :1004-1008
[7]   Activated protein C resistance in ischemic stroke not due to factor V arginine(506)->glutamine mutation [J].
Fisher, M ;
Fernandez, JA ;
Ameriso, SF ;
Xie, DC ;
Gruber, A ;
PaganiniHill, A ;
Griffin, JH .
STROKE, 1996, 27 (07) :1163-1166
[8]   ACTIVATED PROTEIN-C RESISTANCE CAUSED BY ARG506GLN MUTATION IN FACTOR VA [J].
GREENGARD, JS ;
SUN, X ;
XU, X ;
FERNANDEZ, JA ;
GRIFFIN, JH ;
EVATT, B .
LANCET, 1994, 343 (8909) :1361-1362
[9]  
GRIFFIN JH, 1993, BLOOD, V82, P1989
[10]  
GUINTO ER, 1992, J BIOL CHEM, V267, P2971